Hematology Special Issue (October) | CURE

October 20, 2016

A lone dynamo has raised a million dollars for myeloma research through amazing athletic endeavors, such as running 200 miles nonstop.

October 20, 2016

Actress Marlee Matlin shares her strategy for weathering health challenges, including her father's myeloma diagnosis.

October 19, 2016

Anticoagulants can reduce a heightened risk of blood clots in cancer patients.

October 19, 2016

By taking the brakes off immune response, immunotherapy empowers the body to fight resistant or recurrent classical Hodgkin lymphoma.

October 18, 2016

There’s an enormous — and growing — menu of treatments for B cell lymphomas.

October 18, 2016

With its series of hikes, Moving Mountains for Multiple Myeloma inspires donations — and pride.

October 17, 2016

Targeted drugs known as TKIs have improved the prognosis for patients with chronic myeloid leukemia.

October 14, 2016

IN THIS SPECIAL ISSUE of CURE®, among other highlights in the treatment of blood cancers, we detail yet another example of a new application for immunotherapy, this time focusing on the use of PD-1 (checkpoint) immunotherapy to treat Hodgkin lymphoma.

October 13, 2016

IT’S NOT OFTEN that we hear the terms “good news” and“cancer” in the same sentence. But this special issue of CURE® does bring good news — reports of a series of exciting breakthroughs in the blood cancer arena that are significantly improving treatment options for patients.